Screening and management of metabolic, cardiac, and bone health in prostate cancer patients on androgen deprivation therapy A survey of specialized physicians
Can Urol Assoc J
.
2024 Jun;18(6):212-215.
doi: 10.5489/cuaj.8687.
Authors
David-Dan Nguyen
1
,
Ahmad Mousa
1
,
Laurence Klotz
1
2
,
Tamim Niazi
3
,
Frédéric Pouliot
4
,
Andrea Kokorovic
5
,
Luke T Lavallée
6
,
Melissa Huynh
7
,
Nathalie Lapointe
8
,
Michelle Di Risio
8
,
Christopher J D Wallis
1
9
10
Affiliations
1
Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada.
2
Division of Urology, Department of Surgery, Sunnybrook Health Sciences, University of Toronto, ON, Canada.
3
Department of Radiation Oncology, Jewish General Hospital, McGill University, Montreal, QC, Canada.
4
Division of Urology, Department of Surgery, Centre hospitalier de l'Université Laval, Quebec, QC, Canada.
5
Division of Urology, Department of Surgery, Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
6
Division of Urology, Department of Surgery, The Ottawa Hospital, University of Ottawa, Ottawa, ON, Canada.
7
Division of Urology, Department of Surgery, Victoria Hospital, of Western University, London, ON, Canada.
8
Knight Therapeutics, Montreal, QC, Canada.
9
Department of Surgical Oncology, University Health Network, Toronto, ON, Canada.
10
Division of Urology, Department of Surgery, Mount Sinai Hospital, Toronto, ON, Canada.
PMID:
38587979
PMCID:
PMC11230694
DOI:
10.5489/cuaj.8687
No abstract available
Publication types
Letter